Cargando…
Genomic and Transcriptional Profiling of Chinese Melanoma Patients Enhanced Potentially Druggable Targets: A Multicenter Study
SIMPLE SUMMARY: Although multiple actionable genes have been identified in melanoma, 38–42% of patients are still not druggable based on current research. In our study, DNA-NGS and RNA-NGS were utilized to construct molecular profiles of a Chinese cohort of 469 melanoma patients. Up to 11.7% (7/60)...
Autores principales: | Li, Yue, Wang, Baoming, Wang, Chunyang, Zhao, Dandan, Liu, Zhengchuang, Niu, Yanling, Wang, Xiaojuan, Li, Wei, Zhu, Jianhua, Tao, Houquan, Ma, Tonghui, Li, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818204/ https://www.ncbi.nlm.nih.gov/pubmed/36612279 http://dx.doi.org/10.3390/cancers15010283 |
Ejemplares similares
-
Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study
por: Zhou, Shengyu, et al.
Publicado: (2023) -
Molecular characterization of genomic breakpoints of ALK rearrangements in non‐small cell lung cancer
por: Wang, Zizong, et al.
Publicado: (2022) -
Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late‐onset cancers
por: Hao, Shaoyu, et al.
Publicado: (2023) -
PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
por: He, Xujun, et al.
Publicado: (2022) -
Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma
por: Jia, Dong-Dong, et al.
Publicado: (2021)